Skip to main content

People in the News: Feb 2, 2010

Premium

CombiMatrix has tapped Mark McGowan to serve on its board of directors. McGowan is the managing member of SAF Capital Management, and he co-founded and served as managing partner of MPG Capital Management.


Mike Hoerres has joined Geisinger Ventures as a principal. Ventures is Geisinger Health System's for-profit venture arm.

Prior to joining Geisinger, Hoerres was vice president of business development at Source MDx. He also served previously as clinical market development manager at Affymetrix and director of business development at Incyte Genomics.


Sequenom has appointed Wolfgang Holzgreve to its clinical advisory board. Holzgreve currently is director and chairman of the board of directors at the University Hospital Freiburg, Germany, and he formerly was chairman of the department and chief of service at the department of obstetrics and gynecology at the University of Basel.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.